Form 4: Revvity Executive Reports Stock Transactions Following Vesting
SEC Form 4 Filing
Tajinder S. Vohra, a Senior Vice President at Revvity, reports the acquisition and disposal of company stock related to vesting restricted stock units and stock options.
Summary
- On February 4, 2025, Tajinder S. Vohra, a Senior Vice President at Revvity, engaged in transactions involving Revvity's common stock.
- Vohra surrendered 307 shares to cover tax obligations related to the vesting of restricted stock granted on February 4, 2022, at a price of $123.69 per share.
- Vohra also acquired 3,280 shares of time-based restricted stock units, scheduled to fully vest on the third anniversary of the grant date.
- Additionally, Vohra acquired 9,069 non-qualified stock options with an exercise price of $123.35, vesting in three equal annual installments starting February 4, 2023, and expiring on February 4, 2032.
- Following these transactions, Vohra directly owns 22,625 shares of common stock and 9,069 non-qualified stock options.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can be informative for investors.
Comparison to Industry Standards
- Stock-based compensation is a common practice among publicly traded companies to incentivize and retain employees.
- The vesting schedules and terms of the restricted stock units and stock options appear typical for executive compensation packages.
- Comparing Revvity's executive compensation structure with peers like Danaher or Thermo Fisher Scientific would provide a more comprehensive assessment.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect standard executive compensation practices.
- Employees, particularly executives, are directly impacted by the vesting of stock options and restricted stock units.
Key Dates
| Date | Description |
|---|---|
| 02/04/2022 | Date of original grant of restricted stock. |
| 02/04/2023 | First anniversary of the date of grant for stock options, beginning of vesting installments. |
| 02/04/2025 | Date of transactions: stock surrender, acquisition of restricted stock units, and acquisition of stock options. |
| 02/04/2032 | Expiration date of the non-qualified stock options. |
| 02/06/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.